http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012105798-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c413d94973245d6e263987e6f347e119 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_392731655377382eb4db57e8a78b54d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b31896b0595e5629c470c80b74b2d2e4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 |
| filingDate | 2012-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_834db44c6538a50d62c3c1fa7a78685d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4f2ba5fdae5d46e205be615e6c0dbc5 |
| publicationDate | 2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2012105798-A3 |
| titleOfInvention | Composition containing chlorogenic acid for preventing or treating gastroesophageal reflux disease |
| abstract | The present invention relates to a pharmaceutical composition for preventing or treating gastroesophageal reflux disease and to a food composition for preventing or treating gastroesophageal flux disease, which contain chlorogenic acid, the pharmaceutically acceptable salts thereof, or derivatives thereof. The present invention also relates to a method for preventing or treating gastroesophageal reflux disease comprising a step of administrating said pharmaceutical composition to an entity, and to the use of chlorogenic acid, the pharmaceutically acceptable salts thereof, or derivatives thereof. According to the present invention, chlorogenic acid, the pharmaceutically acceptable salts thereof, or derivatives thereof may reduce the area of lesions in the esophagus caused by the reflux of the contents of the stomach or duodenum to the esophagus, without changing the pH level in the stomach, and may reduce histological changes of inflammatory cells, and therefore may be valuably used in preventing or treating gastroesophageal reflux disease with no side effects. |
| priorityDate | 2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.